AFCAPS/TexCAPS acute coronary disease results - Relative risks (and 95% CIs) associated with lovastatin therapy, according to baseline lipid and C-reactive protein levels.
收藏NIAID Data Ecosystem2026-03-07 收录
数据链接：
官方服务：
资源简介：
Data are from Table 2 in [36]. 5 year risk (%), risk of an acute coronary event in the placebo arm group (in other words, this is a baseline risk for this population); A, any hsCRP; H, LDL or hsCRP higher than the median; L, LDL or hsCRP lower than the median.
创建时间：
2013-02-21
